Calamos Advisors’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-150,000
Closed -$1.48M 1436
2022
Q2
$1.48M Hold
150,000
0.01% 951
2022
Q1
$1.49M Hold
150,000
0.01% 957
2021
Q4
$1.49M Hold
150,000
0.01% 945
2021
Q3
$1.5M Hold
150,000
0.01% 814
2021
Q2
$1.53M Hold
150,000
0.01% 760
2021
Q1
$1.51M Buy
+150,000
New +$1.58M 0.01% 727

Other funds holding CPUH.U

Calamos Advisors's CPUH.U Position: Q3 2022 in Review

Calamos Advisors sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q3 2022, closing a stake of 150,000 shares — an estimated $1.48M sold.

Calamos Advisors first reported a position in CPUH.U in Q1 2021 and held it in 6 quarters. The position peaked at $1.53M in Q2 2021. 32 funds tracked by Wall St. Rank hold CPUH.U as of Q3 2022.

  • Calamos Advisors reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q3 2022 after selling out during the quarter.
  • Calamos Advisors sold 150,000 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q3 2022, an estimated $1.48M.
  • Calamos Advisors first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 6 quarters.
  • Calamos Advisors's Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $1.53M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q3 2022.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.